Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis

doi:10.3748/wjg.v18.i36.5135

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 36

This Article

(0)

(4748)

(7)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Gastroenterol. Sep 28, 2012; 18(36): 5135-5137
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5135

Full Size Figure Download Figure

Figure 1 Enteroscopic appearance of the lesions. A: A 4-cm chronic cavity consistent with chronic perforation at the jejunal anastomosis; B: More distal jejunal ulcerations.

Citation: Seven G, Assaad A, Biehl T, Kozarek RA. Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis. World J Gastroenterol 2012; 18(36): 5135-5137
URL: https://www.wjgnet.com/1007-9327/full/v18/i36/5135.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i36.5135

Seven G, Assaad A, Biehl T, Kozarek RA. Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis. World J Gastroenterol 2012; 18(36): 5135-5137 [PMID: 23049226 DOI: 10.3748/wjg.v18.i36.5135]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.